43 related articles for article (PubMed ID: 38657094)
1. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
Zhang B; Liu Y; Yu J; Lin X
Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
[TBL] [Abstract][Full Text] [Related]
2. Exploring the association of POSTN
Lin S; Zhou M; Cheng L; Shuai Z; Zhao M; Jie R; Wan Q; Peng F; Ding S
Int J Biol Macromol; 2024 May; 268(Pt 1):131560. PubMed ID: 38631570
[TBL] [Abstract][Full Text] [Related]
3. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
He ZX; Li J; Wang QF; Cheng Q; Ni SJ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
[No Abstract] [Full Text] [Related]
4. Exosomal miRNA-92a derived from cancer-associated fibroblasts promote invasion and metastasis in breast cancer by regulating G3BP2.
Sheng Z; Wang X; Ding X; Zheng Y; Guo A; Cui J; Ma J; Duan W; Dong H; Zhang H; Cui M; Su W; Zhang B
Cell Signal; 2024 Jul; 119():111182. PubMed ID: 38640983
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells.
Jin X; Yang S; Lu X; Chen X; Dai W
Breast Cancer Res; 2024 Jun; 26(1):92. PubMed ID: 38840145
[TBL] [Abstract][Full Text] [Related]
6. ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1.
Song W; Tang L; Xu Y; Sun Q; Yang F; Guan X
J Exp Clin Cancer Res; 2017 Jun; 36(1):75. PubMed ID: 28583190
[TBL] [Abstract][Full Text] [Related]
7. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
[TBL] [Abstract][Full Text] [Related]
8. YAP1-induced RBM24 promotes the tumorigenesis of triple-negative breast cancer through the β-catenin pathway.
Chen X; Lin X; Xia X; Xiang X
J Investig Med; 2024 Jun; 72(5):403-413. PubMed ID: 38441112
[TBL] [Abstract][Full Text] [Related]
9. Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer.
Yang X; Li F; Shi Y; Wu Y; Yang R; Liu X; Zhang Y; Zhang G; Ma M; Luo Z; Han X; Xie Y; Liu S
Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):763-775. PubMed ID: 38516703
[TBL] [Abstract][Full Text] [Related]
10. MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer.
Iida M; Crossman BE; Kostecki KL; Glitchev CE; Kranjac CA; Crow MT; Adams JM; Liu P; Ong I; Yang DT; Kang I; Salgia R; Wheeler DL
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791148
[TBL] [Abstract][Full Text] [Related]
11. YTHDC1-dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple-negative breast cancer.
Shen X; Zhong J; Yu P; Liu F; Peng H; Chen N
Cancer Sci; 2024 Jun; 115(6):1881-1895. PubMed ID: 38566554
[TBL] [Abstract][Full Text] [Related]
12. PTGER3 knockdown inhibits the vulnerability of triple-negative breast cancer to ferroptosis.
Wang S; Zhang Y; Zhang D; Meng J; Che N; Zhao X; Liu T
Cancer Sci; 2024 Jun; 115(6):2067-2081. PubMed ID: 38566528
[TBL] [Abstract][Full Text] [Related]
13. MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer.
Zheng SM; Feng YC; Zhu Q; Li RQ; Yan QQ; Teng L; Yue YM; Han MM; Ye K; Zhang SN; Qi TF; Tang CX; Zhao XH; Zhang YY; Xu L; Xu R; Xing J; Baker M; Liu T; Thorne RF; Jin L; Preiss T; Zhang XD; Cang S; Gao JN
Cancer Res; 2024 May; 84(9):1460-1474. PubMed ID: 38593213
[TBL] [Abstract][Full Text] [Related]
14. Structural clarification of mannoglucan GSBP-2 from Ganoderma sinense and its effects on triple-negative breast cancer migration and invasion.
Xie Y; Su Y; Wang Y; Zhang D; Yu Q; Yan C
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131903. PubMed ID: 38688342
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitizing effect of a novel CTSS inhibitor by enhancing BRCA1 protein stability in triple-negative breast cancer cells.
Choi E; Jeon KH; Lee H; Mun GI; Kim JA; Shin JH; Kwon Y; Na Y; Lee YS
Cancer Sci; 2024 Jun; 115(6):2036-2048. PubMed ID: 38613358
[TBL] [Abstract][Full Text] [Related]
16. Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis.
Xie H; Ruan G; Wei L; Zhang H; Shi J; Lin S; Liu C; Liu X; Zheng X; Chen Y; Deng L; Shi H
Int Immunopharmacol; 2024 May; 136():112332. PubMed ID: 38805776
[TBL] [Abstract][Full Text] [Related]
17. METTL3 orchestrates glycolysis by stabilizing the c-Myc/WDR5 complex in triple-negative breast cancer.
Yuan XN; Shao YC; Guan XQ; Liu Q; Chu MF; Yang ZL; Li H; Zhao S; Tian YH; Zhang JW; Wei L
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119716. PubMed ID: 38547933
[TBL] [Abstract][Full Text] [Related]
18. NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal.
Yoon SO; Kim EK; Lee M; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Oncotarget; 2016 Jan; 7(3):2475-95. PubMed ID: 26673617
[TBL] [Abstract][Full Text] [Related]
19. PYCR1 expresses in cancer-associated fibroblasts and accelerates the progression of C6 glioblastoma.
Zhang M; Bi B; Liu G; Fan X
Histol Histopathol; 2024 May; ():18762. PubMed ID: 38826151
[TBL] [Abstract][Full Text] [Related]
20. Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis.
Zhao CC; Chen J; Zhang LY; Liu H; Zhang CG; Liu Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33416073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
